Anna Morris KC addresses Module 4 Preliminary Hearing in Covid-19 Inquiry

14 September 2023

Anna Morris KC and Christian Weaver, instructed by Terry Wilcox at Hudgells Solicitors, represent over 1,000 people who have suffered an adverse reaction or bereavement as a result of the Covid-19 vaccine.

Yesterday, in their opening statement to the UK Covid-19 Inquiry preliminary hearing for Module 4, which will focus on vaccines and therapeutics, they highlighted the historic opportunity the Inquiry has to listen, acknowledge and record the experiences of the vaccine injured, and to radically reform the medical, psychological and financial support they receive.

Anna Morris KC leads the team which represents the Vaccine Injured and Bereaved UK, Scottish Vaccine Injury Group, and UK CV Family, alongside GCN’s Christian Weaver and Mark Bradley from Deans Court Chambers.

You can read a transcript of the hearing.

Media coverage of Anna’s appearance can be found below:
Daily Mail Online
The Herald

News

News

Garden Court North’s crime team: Government’s ill-considered proposals to limit jury trials will result in irrevocable damage for no tangible gain

Garden Court North's crime team unequivocally opposes the Government’s proposal to restrict the right to a jury trial.

News

Robert Rhodes avoids whole life term following rare retrial for murder

Garden Court North's Nina Grahame KC represented Mr Rhodes, who was sentenced to 29-and-a-half years in a rare double jeopardy case.

News

Nina Grahame KC represents vulnerable defendant in tragic manslaughter case

Garden Court North's Nina Grahame KC represented the Defendant during their guilty plea on Tuesday (13 January 2026).

News

Bereaved families and Pete Weatherby KC call on Government to include security services in Hillsborough Law’s Duty of Candour

Bereaved families from Hillsborough and the Manchester Arena bombing call on Government to include security services in Hillsborough Law.

Sign up to our mailing list

Our mailing list is dedicated to professionals with an interest in our work.

Sign up